医学
创伤性脑损伤
凝血病
重症监护医学
纤溶
抗血栓
生物信息学
外科
内科学
精神科
生物
出处
期刊:Neurosurgery
[Lippincott Williams & Wilkins]
日期:2021-09-08
卷期号:89 (6): 954-966
被引量:36
标识
DOI:10.1093/neuros/nyab358
摘要
Whether timely and targeted management of hemostatic abnormalities after TBI can protect against secondary brain injury and thereby improve outcomes remains elusive. Innovative technologies for diagnostics and monitoring offer windows of opportunities for precision medicine approaches to managing TBI.
科研通智能强力驱动
Strongly Powered by AbleSci AI